D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-11.65%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$55.2B
AUM Growth
-$8.61B
Cap. Flow
+$1.32B
Cap. Flow %
2.39%
Top 10 Hldgs %
11.29%
Holding
2,915
New
345
Increased
1,136
Reduced
975
Closed
299

Sector Composition

1 Technology 19.62%
2 Consumer Discretionary 15.28%
3 Healthcare 14.47%
4 Financials 9.86%
5 Industrials 8.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HT
2351
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$186K ﹤0.01%
10,578
-23,645
-69% -$416K
EARN
2352
Ellington Residential Mortgage REIT
EARN
$213M
$185K ﹤0.01%
+18,091
New +$185K
ABUS icon
2353
Arbutus Biopharma
ABUS
$889M
$184K ﹤0.01%
48,047
-12,509
-21% -$47.9K
NXEO
2354
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$181K ﹤0.01%
21,013
-76,982
-79% -$663K
VRDN icon
2355
Viridian Therapeutics
VRDN
$1.62B
$179K ﹤0.01%
+3,940
New +$179K
IPI icon
2356
Intrepid Potash
IPI
$390M
$178K ﹤0.01%
6,877
-3,593
-34% -$93K
AVX
2357
DELISTED
AVX Corporation
AVX
$178K ﹤0.01%
11,693
-63,697
-84% -$970K
TFSL icon
2358
TFS Financial
TFSL
$3.75B
$177K ﹤0.01%
10,996
-9,302
-46% -$150K
VG
2359
DELISTED
Vonage Holdings Corporation
VG
$176K ﹤0.01%
20,176
-193,725
-91% -$1.69M
CTSO icon
2360
Cytosorbents Corp
CTSO
$59M
$174K ﹤0.01%
+21,583
New +$174K
ICL icon
2361
ICL Group
ICL
$8.07B
$174K ﹤0.01%
30,679
-86
-0.3% -$488
ACET
2362
DELISTED
Aceto Corp
ACET
$174K ﹤0.01%
206,525
+194,725
+1,650% +$164K
LILAK icon
2363
Liberty Latin America Class C
LILAK
$1.55B
$171K ﹤0.01%
12,447
-355,601
-97% -$4.89M
IVR icon
2364
Invesco Mortgage Capital
IVR
$515M
$170K ﹤0.01%
+1,172
New +$170K
NPTN
2365
DELISTED
NEOPHOTONICS CORP
NPTN
$170K ﹤0.01%
26,209
-176,896
-87% -$1.15M
MDR
2366
DELISTED
McDermott International
MDR
$170K ﹤0.01%
26,000
-10,611
-29% -$69.4K
ORIT
2367
DELISTED
Oritani Financial Corp. New
ORIT
$169K ﹤0.01%
+11,450
New +$169K
STML
2368
DELISTED
Stemline Therapeutics, Inc.
STML
$168K ﹤0.01%
17,675
-85,939
-83% -$817K
USX
2369
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$165K ﹤0.01%
+29,363
New +$165K
RCKT icon
2370
Rocket Pharmaceuticals
RCKT
$344M
$165K ﹤0.01%
11,166
-13,890
-55% -$205K
PVTL
2371
DELISTED
Pivotal Software, Inc.
PVTL
$165K ﹤0.01%
+10,096
New +$165K
PRMW
2372
DELISTED
Primo Water Corporation
PRMW
$158K ﹤0.01%
11,266
-116,099
-91% -$1.63M
GRTS
2373
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$157K ﹤0.01%
+10,130
New +$157K
VGR
2374
DELISTED
Vector Group Ltd.
VGR
$154K ﹤0.01%
+23,408
New +$154K
NVAX icon
2375
Novavax
NVAX
$1.29B
$152K ﹤0.01%
4,139
-278
-6% -$10.2K